Molecular and Cellular Biomedical Technologies
Why should you choose «Molecular and Cellular Biomedical Technologies»?
- The strong connection between Education and Science
- Interdisciplinary knowledge at the intersection of biology, pharmacology, cell, and molecular medicine.
- Skills and knowledge at the new biomedical technologies
- Prospective employment in Scientific research
Key competencies and skills that you will develop
- Research skills in molecular and cellular biology, immunobiotechnology
- Up-to-date technologies for drug and vaccine design
- Skills in molecular modelling and bioinformatics
- Basics of the preclinical trials
About the program
Fundamental background & Practical skills in the following fields:
SPbPU diploma: Master of Science
Graduates will be able to work in various fields of Biomedicine: from bacteriology and virology, to genetics and laboratory diagnostics:
2 years, full-time
Special focus is set on molecular and cellular approaches for development of therapies against socially significant diseases such as viral and bacterial infections, cancer and autoimmune diseases, hereditary diseases.
Major areas of expertise:
Tuition fee per year:
The program is taught in English
1st semester (30 ECTS)
2nd semester (30 ECTS)
3rd semester (30 ECTS)
4th semester (30 ECTS)
- Preparation and characterization of a reassortant candidate vaccine strain of influenza virus A / UNL / HK/2:6/2017(H5N8)
- Molecular genetic characteristics of influenza A viruses circulating in Russia during the epidemic seasons 2016-2018
- Adaptation of influenza virus H2N2 to reproduction in the lungs of mice and analysis of concomitant mutations
- Physicochemical and structural characteristics of recombinant proteins based on M2 and HA2 influenza A viruses
- Variability of the F and G genes of human respiratory syncytial virus strains isolated in 2014-2016 in St. Petersburg
- The study of cold adapted influenza vector with the insertion of tuberculosis antigen ESAT6
- The role of reactive oxygen species in the regulation of proliferation of human embryonic stem cells
- Physico-chemical characterization of SQSTM1 protein and its deletion form
- The neuroprotective effect of CGRP in hyperactivation of glutamate receptors in neurons of the cerebral cortex and cerebellum in vitro
- Cloning and characterization of α-L-fucosidase from Fusarium proliferatum LE1
Laboratory of molecular neurodegeneration
The main Research areas at the laboratory are fundamental and applied research in Neuroscience, neuropathology, and neurophysiology
Laboratory of microencapsulation and controlled delivery of biologically active compounds
The main Research area of the center connected to the developing and application of biotechnological systems for targeting and delivery different biological compounds using microencapsulation.
Scientific and educational complex "Immunobiotechnology and gene therapy" (in collaboration with the Smorodintsev Research Institute of Influenza)
Development of vaccines and immunotherapy approaches against infectious diseases. The Center is specialized in viral vector and recombinants vaccines, RNA vaccines and therapy.
Scientific and educational complex "Nanobiotechnologies"
The Center uses the most advanced experimental approaches to study the composition and structure of the most complex biological objects, identify their functions at the cellular and subcellular levels, determine trace amounts of metabolites in human vital products, study the most complex biochemical processes at the molecular level, study the dynamics of nanobiomachines at a single molecular level, use gene therapy.
Research Laboratory "Molecular Virology and Oncology"
The main focus of the laboratory is connected with fundamental Research and the development of modern biomedical approaches for detection and treatment of viral infections and cancer using molecular biology, biotechnology and gene engineering.
Leading professors and guest speakers:
Joeri Aerts, Vrije Universiteit Brussel
(Н –index 23)
Professor, Laboratory of Molecular and Cellular Therapy (LMCT), Vrije Universiteit Brussel
(Н –index 57)
Professor, Department of Physiology, University of Texas Southwestern Medical Center, PI Laboratory of Molecular Neurodegeneration, Peter the Great St. Petersburg Polytechnic University.
Professor of Biomedical Materials Institute of Bioengineering, Queen Mary University of London.
Professor Maria S. Salvato, PhD
Head of the Laboratory of Arenavirus Disease & Vaccines; Professor in the Division of Infectious Agents and Cancer, Institute of Human Virology, University of Maryland School of Medicine, Baltimore.
Andrej Egorov, MD, PhD
(Н –index 21)
Vacthera Bio Tech GmbH, Vienna, Austria Smorodintsev Research Institute of Influenza, St-Petersburg, Russia Specialization – immunology, microbiology, biochemistry, genetics, molecular biology